[en] •Partial correction (Hb in the range of 10-11.5 g/dL) of CKD-related anemia appears a safer strategy during the last 5y. So recommendation is to start ESA only when Hb <10 and to avoid too high ESA dose (CE DOSE study ongoing in HD)!
•Identify resistant patients and try to improve it.
•Importance of adequate iron management and of hepcidin role in the all-mortality risk in CKD.
Newer strategies for correcting anemia are currently explored
Disciplines :
Urology & nephrology
Author, co-author :
Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie
Language :
English
Title :
What is new in anemia treatment in CKD since 2010?
